David Stone 5/11/23 David Stone 5/11/23 BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance Read More
David Stone 5/11/23 David Stone 5/11/23 BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance Read More